Capecitabine in combination with Docetaxel in first line in HER2-Negative metastatic breast cancer an observational study /
Due to the limited experience with capecitabine plus docetaxel (XT) combination in the first-line treatment of metastatic breast cancer in Hungary, the main objective of the study was to analyze the effectiveness and tolerability of XT therapy. A prospective, open-label, non-randomized, single-arm,...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
Springer Netherlands
2017
|
| Sorozat: | PATHOLOGY AND ONCOLOGY RESEARCH
23 No. 3 |
| doi: | 10.1007/s12253-016-0129-7 |
| mtmt: | 3151638 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/12504 |